Bristol-Myers Squibb Co
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 […]
Read More
Stocks making the biggest moves midday: Duolingo, Tesla, Boeing, Gildan Activewear and more
Check out the companies making headlines in midday trading: Duolingo — Shares surged more than 9% following Morgan Stanley’s initiation of the language learning platform at overweight. The bank set a Wall Street-high price target on Duolingo shares and called the stock a “best-in-class consumer internet asset.” Tesla — Shares of the electric vehicle maker […]
Read More
Stocks making the biggest moves premarket: Boeing, Tesla, BP, Eli Lilly and more
Check out the companies making headlines before the bell. Boeing – The aerospace stock rose more than 5% after the company reported a narrower loss for the first quarter . Boeing said it had a net loss of $31 million in the first quarter, improving on the $355 million loss in the same period last […]
Read More
Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more
Check out the companies making headlines in extended trading: Tesla — Shares were marginally lower in extended trading after first-quarter results missed analysts’ estimates on the top and bottom lines. The electric vehicle company earned an adjusted 27 cents per share on revenue of $19.34 billion, while analysts polled by LSEG were looking for 39 […]
Read More
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
U.S. President Donald Trump speaks to the media during the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to […]
Read More
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
10 beaten-up stocks that are candidates for a rebound — but all are not created equal
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are struggling to hold onto gains Tuesday with the market well off its highest levels of the session. Deeply oversold conditions combined with some […]
Read More
Hard-hit Apple bounces back with the market, and an analyst is divided on our drug stocks
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Wall Street surged Tuesday on increased hopes of tariff deals, following a wickedly volatile session Monday. The Dow Jones Industrial Average climbed around 1,400 points, or 3.7%. The S […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More